Welcome to our dedicated page for Microchip Technology SEC filings (Ticker: MCHP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Microchip Technology Inc. (NASDAQ: MCHP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed information about its semiconductor business, governance and financial condition. As a Delaware corporation headquartered in Chandler, Arizona, Microchip reports as a public company on the Nasdaq Global Select Market, and its regulatory filings are a primary source for understanding MCHP stock.
On this page, investors can review Microchip’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its role as a broadline supplier of semiconductors serving industrial, automotive, consumer, aerospace and defense, communications and computing markets. These reports typically include discussions of segment performance, risk factors, research and development, and other disclosures relevant to the company’s embedded control and semiconductor portfolio.
Microchip also submits current reports on Form 8-K to announce material events. For example, an 8-K dated November 6, 2025 reports the announcement of results for the second quarter of fiscal year 2026, while an 8-K dated August 20, 2025 details the outcomes of the company’s annual meeting of stockholders, including director elections, auditor ratification and an advisory vote on executive compensation.
Definitive proxy statements on Form DEF 14A provide insight into Microchip’s governance, board composition, executive compensation and stockholder voting procedures. The July 7, 2025 proxy statement outlines the agenda for the 2025 annual meeting, the proposals presented to stockholders and information about how to vote.
Stock Titan’s SEC filings page surfaces these documents as they are made available on EDGAR and can pair them with AI-powered summaries that explain key points, such as changes in guidance, voting results or governance matters. Users can quickly locate Forms 10-K, 10-Q, 8-K and DEF 14A related to Microchip Technology, helping them analyze MCHP’s regulatory history, monitor material events and understand the disclosures that shape the company’s profile in the semiconductor industry.
Joseph R. Krawczyk II, Senior Vice President, Worldwide Client Engagement at Microchip Technology Incorporated (MCHP), reported changes in his beneficial ownership on 10/01/2025. The filing shows a disposition of 16,315 shares of common stock (reported as Code V). On the same date he was credited with multiple equity awards: 1,755 restricted stock units (RSUs), 1,755 performance stock units (PSUs), and several additional RSU/PSU tranches of 75, 124, and 125 units. The RSUs vest on specified dates in 2027, 2028, and 11/15/2029 provided continued service; vested RSUs will be delivered as common stock. The PSUs vest on 11/15/2028 and 11/15/2029 subject to service and achievement of a cumulative 29.0% non-GAAP operating margin over 12 quarters ending 9/30/2028
Microchip Technology (MCHP) Form 4: A Senior VP, Operations reported equity awards and updated holdings. The officer received 2,339 restricted stock units (RSUs) that vest on November 15, 2029, and 2,340 performance stock units (PSUs) whose payout depends on Microchip’s cumulative non-GAAP operating margin over 12 quarters ending September 30, 2028, with earned PSUs vesting on November 15, 2029. The filing also shows smaller grants of 69 RSUs and 69 PSUs vesting on November 15, 2028. Each RSU/PSU represents a right to one share upon vesting. Following the reported transactions, common stock beneficially owned is 29,736 shares, held directly.
James Eric Bjornholt, Senior VP and CFO of Microchip Technology Incorporated (MCHP), reported equity awards on 10/01/2025 on Form 4. The filing shows 30,089 shares held indirectly in a trust. On the same date he was granted 3,071 restricted stock units (RSUs) and 3,071 performance stock units (PSUs), each unit representing a contingent right to one share.
The RSUs will vest in full on November 15, 2029 provided continued service. The PSUs vest on the same date but are earned only if Microchip achieves a cumulative non-GAAP operating margin of 29.0% over the 12-quarter period ending September 30, 2028; actual PSU payout can be higher or lower than target.
Insider purchase reported: Richard J. Simoncic, Chief Operating Officer of Microchip Technology Inc. (MCHP), acquired 56 shares of Microchip common stock under the companys 2001 Employee Stock Purchase Plan on 09/02/2025 at a price of $49.2575 per share. The acquisition was an exempt transaction under Rule 16(b)-3(d) and was paid for by contributions made during the six-month period ended 08/31/2025. After the transaction, Mr. Simoncic beneficially owns 151,057 shares indirectly through a trust. The Form 4 was signed by an attorney-in-fact on 09/03/2025.
Steve Sanghi, President, CEO and Chair of Microchip Technology Inc. (MCHP), acquired 282 shares on September 2, 2025 under the companys 2001 Employee Stock Purchase Plan at a price of $49.2575 per share. After this transaction he is reported to beneficially own 10,167,682 shares indirectly through The Sanghi Trust (4,261,810 shares) and The Sanghi Family Limited Partnership (5,905,872 shares). The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on September 3, 2025. The purchase is described as an exempt transaction under Rule 16(b)-3(d) funded by contributions during the six-month ESPP period ended August 31, 2025.
Joseph R. Krawczyk II, Senior Vice President, Worldwide Client Engagement at Microchip Technology Inc. (MCHP), acquired 110 shares of Microchip common stock on 09/02/2025 at a purchase price of $49.2575 per share under the company's 2001 Employee Stock Purchase Plan. The filing reports the shares were purchased in an exempt transaction pursuant to Rule 16(b)-3(d) and paid for by contributions made during the six-month offering period ended 08/31/2025. Following the transaction, Mr. Krawczyk beneficially owns 16,315 shares directly. The Form 4 was signed by an attorney-in-fact on 09/03/2025.
Microchip Technology Inc. (MCHP) reporting person Mathew B. Bunker, Senior VP, Operations, acquired 123 shares of common stock on 09/02/2025 under the company's 2001 Employee Stock Purchase Plan at a purchase price of $49.2575 per share. The acquisition was exempt under Rule 16(b)-3(d) and funded by payroll contributions during the six months ended August 31, 2025. After the purchase, the reporting person beneficially owned 29,736 shares. The Form 4 was signed by an attorney-in-fact on 09/03/2025.
Form 4 filing for Microchip Technology Inc. (MCHP) reports that James Eric Bjornholt, Senior Vice President and Chief Financial Officer, acquired 79 shares of Microchip common stock on 09/02/2025 at a price of $49.2575 per share under the company's 2001 Employee Stock Purchase Plan. After the transaction, Mr. Bjornholt beneficially owns 30,089 shares indirectly through a trust. The acquisition was made in an exempt transaction pursuant to Rule 16(b)-3(d) and was paid for by contributions during the six-month purchase period ending August 31, 2025. The Form 4 was signed via attorney-in-fact.
Microchip Technology Inc (MCHP) Form 144/A notifies a proposed sale of 7,356 shares of common stock via Merrill (San Francisco) with an aggregate market value of $508,593.84, approximately 8/25/2025 on Nasdaq. The securities were acquired primarily as restricted stock units (RSUs) from Microchip Technology between 02/18/2020 and 08/15/2025, in lots including 3,053, 1,024 and smaller grants; payment was in cash when applicable. The filer, identified by prior sales, sold 2,015 shares on 05/23/2025 for gross proceeds of $112,275.80. The filer represents no undisclosed material adverse information and acknowledges legal attestation.
Microchip Technology Inc. insider Richard J. Simoncic, listed as Chief Operating Officer, reported a sale of 2,000 shares of Microchip common stock on 08/22/2025 at a price of $69.14 per share. After the transaction he is reported to beneficially own 151,001 shares indirectly through a trust. The Form 4 was signed by an attorney-in-fact on 08/27/2025. No derivative transactions or additional remarks were disclosed in the filing.